Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.

Also called NCT01354925

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 245 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01354925
Other papers using this trial's data
  • Effect of a new insulin treatment regimen on glycaemic control and quality of life of Muslim patients with type 2 diabetes mellitus during Ramadan fast - an open label, controlled, multicentre, cluster randomised study International journal of clinical practice, 2015-11 DOI, PubMed 26234442

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01354925. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
Acronym
DMR
Condition
Diabetes Type 2
Condition
Treatment During Ramadan
Intervention (Drug)
Insulin treatment during Ramadan
Intervention (Drug)
Standard of care
Lead sponsor
Meir Medical Center (class: other)

Record details

Record id
cardio:ct-nct01354925
Content hash
2593f676b161f003b2123bacbfcd9db0aca83ccc76ffa2700563f795f6ee95fd